Zobrazeno 1 - 10
of 199
pro vyhledávání: '"MR Loken"'
Publikováno v:
Blood. 77:1218-1227
Multiparameter flow cytometry was applied on normal human bone marrow (BM) cells to study the lineage commitment of progenitor cells ie, CD34+ cells. Lineage commitment of the CD34+ cells into the erythroid lineage was assessed by the coexpression of
Publikováno v:
Blood. 76:1739-1747
The low frequency of plasma cells and the lack of specific cell surface markers has been a major obstacle for a detailed characterization of plasma cells in normal human bone marrow. Multiparameter flow cytometry enabled the identification of plasma
Publikováno v:
Blood. 71:528-531
Different stages of B lymphoid maturation were identified in normal bone marrow using multiple cell surface markers. The proliferation status of each of these maturational stages was determined by simultaneous quantitative DNA analysis on a flow cyto
Publikováno v:
Blood. 72(1)
Cell surface phenotypes of 113 B lineage acute lymphocytic leukemia (ALL) cases, defined by the presence of HLA-DR and at least one B-cell- specific antigen (either CD19, CD20, or CD22), were compared with antigen-defined stages of normal B lymphocyt
Publikováno v:
Blood. 69(1)
Flow cytometry was used to identify maturational differences of erythroid lineage cells in normal human bone marrow by combining physical characteristics, the expression of multiple cell surface antigens, and nucleic acid content. Normal low-density
Publikováno v:
Blood. 70(5)
A panel of B lymphoid-reactive monoclonal antibodies was used to analyze the phenotypic changes that accompany B lymphocyte development in normal human bone marrow. The B lymphoid cells were identified using light scattering and the expression of CD1
Autor:
Jacoby MA; Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA., Duncavage ED; Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA., Khanna A; Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.; Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA., Chang GS; McDonnell Genome Institute, Washington University School of Medicine, St Louis, MO, USA., Nonavinkere Srivatsan S; Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA., Miller CA; Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA., Gao F; Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St Louis, MO, USA., Robinson J; Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.; Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA., Shao J; Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA., Fulton RS; McDonnell Genome Institute, Washington University School of Medicine, St Louis, MO, USA., Fronick CC; McDonnell Genome Institute, Washington University School of Medicine, St Louis, MO, USA., O'Laughlin M; McDonnell Genome Institute, Washington University School of Medicine, St Louis, MO, USA., Heath SE; Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA., Brendel K; Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA., Chavez M; Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA., DiPersio JF; Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA., Abboud CN; Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA., Stockerl-Goldstein K; Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA., Westervelt P; Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.; MaineHealth Cancer Center, Scarborough, ME, USA., Cashen A; Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA., Pusic I; Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA., Oh ST; Division of Hematology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA., Welch JS; Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.; A2 Biotherapeutics Inc., Agoura Hills, CA, USA., Wells DA; Hematologics Inc., Seattle, WA, USA., Loken MR; Hematologics Inc., Seattle, WA, USA., Uy GL; Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA. guy@wustl.edu., Walter MJ; Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA. mjwalter@wustl.edu.
Publikováno v:
Leukemia [Leukemia] 2024 Oct 04. Date of Electronic Publication: 2024 Oct 04.
Autor:
Menssen AJ; Hematologics Inc., Seattle, WA. amenssen@hematologics.com., Hudson CA; Hematologics Inc., Seattle, WA., Alonzo T; Children's Oncology Group, Monrovia, CA, USA; Department of Preventive Medicine, University of Southern California, Los Angeles, CA., Gerbing R; Children's Oncology Group, Monrovia, CA., Pardo L; Hematologics Inc., Seattle, WA., Leonti A; Fred Hutchinson Cancer Research Center, Seattle WA., Cook JA; Hematologics Inc., Seattle, WA., Hsu FC; Hematologics Inc., Seattle, WA., Lott LL; Hematologics Inc., Seattle, WA., Dai F; Hematologics Inc., Seattle, WA., Fearing C; Hematologics Inc., Seattle, WA., Ghirardelli K; Hematologics Inc., Seattle, WA., Hylkema T; Fred Hutchinson Cancer Research Center, Seattle WA., Tarlock K; Fred Hutchinson Cancer Research Center, Seattle WA, USA; Seattle Children's Hospital, Cancer and Blood Disorders Center, Department of Hematology/Oncology, Seattle, WA., Loeb KR; Fred Hutchinson Cancer Research Center, Seattle WA, USA; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA., Kolb EA; Children's Oncology Group, Monrovia, CA, USA; Nemours Center for Cancer and Blood Disorders Nemours/A.I. DuPont Hospital for Children, Wilmington DE., Cooper T; Seattle Children's Hospital, Cancer and Blood Disorders Center, Department of Hematology/Oncology, Seattle, WA., Pollard J; Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA., Wells DA; Hematologics Inc., Seattle, WA., Loken MR; Hematologics Inc., Seattle, WA., Aplenc R; Children's Hospital of Philadelphia, Philadelphia, PA., Meshinchi S; Children's Oncology Group, Monrovia, CA, USA; Fred Hutchinson Cancer Research Center, Seattle WA., Brodersen LE; Hematologics Inc., Seattle, WA.
Publikováno v:
Haematologica [Haematologica] 2024 Oct 01; Vol. 109 (10), pp. 3182-3193. Date of Electronic Publication: 2024 Oct 01.
Autor:
Bhagwat AS; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Torres L; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Immunology Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Shestova O; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Shestov M; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Mellors PW; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Fisher HR; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Farooki SN; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Frost BF; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Loken MR; Hematologics Inc., Seattle, WA, USA., Gaymon AL; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Frazee D; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Rogal W; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Frey N; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cell Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA., Hexner EO; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cell Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA., Luger SM; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Loren AW; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cell Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA., Martin ME; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cell Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA., McCurdy SR; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cell Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA., Perl AE; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cell Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA., Stadtmauer EA; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cell Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA., Brogdon JL; Novartis Biomedical Research, Cambridge, MA, USA., Fraietta JA; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Hwang WT; Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, PA, USA., Siegel DL; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA., Plesa G; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA., Aplenc R; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Porter DL; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cell Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA., June CH; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA., Gill SI; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. saar.gill2@pennmedicine.upenn.edu.; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA. saar.gill2@pennmedicine.upenn.edu.; Center for Cell Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA. saar.gill2@pennmedicine.upenn.edu.
Publikováno v:
Nature medicine [Nat Med] 2024 Sep 27. Date of Electronic Publication: 2024 Sep 27.
Autor:
Le Q, Hadland B, Smith JL, Leonti A, Huang BJ, Ries R, Hylkema TA, Castro S, Tang TT, McKay CN, Perkins L, Pardo L, Sarthy J, Beckman AK, Williams R, Idemmili R, Furlan S, Ishida T, Call L, Srivastava S, Loeb AM, Milano F, Imren S, Morris SM, Pakiam F, Olson JM, Loken MR, Brodersen L, Riddell SR, Tarlock K, Bernstein ID, Loeb KR, Meshinchi S
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 2024 Aug 15; Vol. 134 (16). Date of Electronic Publication: 2024 Aug 15.